Industry

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, and its partner Clinilabs Drug Development Corporation (“Clinilabs”), a global, full-service contract research organization with deep expertise in central nervous system drug development, today announced that the U.S. Drug Enforcement Agency (“DEA”) has granted a Schedule … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that in the last twelve months, the United States Patent and Trademark Office has granted eight patents and allowed four patent applications related to the company’s sacral … [Read more…]

LifeWorks Mental Health IndexTM reveals managers and young employees are most likely to feel tension or conflict at work CHICAGO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its monthly Mental Health IndexTM revealing 51 percent of Americans report negative impacts on their children due to the events over the … [Read more…]

Global Conference Aims to Merge and Advance Globally Dispersed Knowledge in Science and Apply Information Technology to Identify New Treatments for Neurodegenerative Disorders INDRC Pioneers Combination of Biological Sciences and Medicine with Big Data and Artificial Intelligence Approaches to Study Function and Information Processing of Healthy and Diseased Human Brain Near-Term Goal to Construct High-Performance … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Healthcare Provider Network Management Market Research Report by Component (Services and Software), Delivery Mode, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Healthcare Provider Network Management Market size was estimated at … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Healthcare Discount Plan Market Research Report by Service (Alternative Medicines, Chiropractic Care, and Dental Care), Deployment Model, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Healthcare Discount Plan Market size was … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Animal Mental Health Monitoring Software Market Research Report by End User (Academic & Research Institutes, Owners, and Veterinarians), Deployment, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Animal Mental Health Monitoring Software Market … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Regenerative Medicine Partnering Terms and Agreements 2015 to 2022” report has been added to ResearchAndMarkets.com’s offering. This report is intended to provide the reader with an in-depth understanding and access to Regenerative Medicine trends and structure of deals entered into by leading companies worldwide. Regenerative Medicine Partnering Terms and Agreements includes: Trends … [Read more…]

LifeWorks Mental Health Index™ finds the treatment employees receive from their company has more influence on buying/investment decisions TORONTO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its monthly Mental Health Index™ that showed 56 per cent of Canadians report negative impacts on their children due to events over the … [Read more…]

SEOUL, South Korea–(BUSINESS WIRE)–Genexine (KOSDAQ: 095700), a publicly traded, clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet medical needs, today announced the dosing of the first patient in phase 2 clinical trial using triple combination therapy in patients with recurrent/metastatic HNSCC. The combination therapy consists … [Read more…]